Agenda Details

Learn more about sessions and presentations at the 25th Annual Meeting

Detailed Program

Emerging Clinical and Pre-Clinical Approaches to Oncolytics

Oncolytic virus therapy has the potential to become a new arm of anti-cancer treatment, potentially augmenting existing immunotherapy approaches such as PD-1 inhibition and replacing others, such as chemotherapy, as combination partners for immunotherapy. In this workshop, the key leaders in the development of oncolytic virus therapy will present new approaches both in the lab and in the clinic in the development of oncolytic virus therapy.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.